Parkinson's Disease 3 Medical, surgical, and physical treatments for Parkinson's disease

被引:0
作者
Foltynie, Tom [1 ]
Bruno, Veronica [2 ]
Fox, Susan [3 ,4 ]
Kuehn, Andrea A. [5 ,6 ,7 ]
Lindop, Fiona [8 ]
Lees, Andrew J. [1 ,9 ]
机构
[1] Natl Hosp Neurol & Neurosurg, UCL Inst Neurol, Dept Clin & Movement Neurosci, London WC1N 3BG, England
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Toronto Western Hosp, Krembil Brain Inst, Edmond J Safra Program Parkinson Dis, Toronto, ON, Canada
[4] Univ Toronto, Div Neurol, Toronto, ON, Canada
[5] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany
[6] Charite Univ Med Berlin, NeuroCure Cluster Excellence, Berlin, Germany
[7] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[8] Univ Hosp Derby & Burton NHS Fdn Trust, Florence Nightingale Community Hosp, Specialist Rehabil, Derby, England
[9] UCL, Reta Lila Weston Inst Neurol Studies, London, England
关键词
DEEP-BRAIN-STIMULATION; SLEEP BEHAVIOR DISORDER; PLACEBO-CONTROLLED TRIAL; OXIDASE B INHIBITORS; DOUBLE-BLIND; SUBTHALAMIC NUCLEUS; MOTOR FLUCTUATIONS; OPEN-LABEL; SUBCUTANEOUS APOMORPHINE; SYMPTOMATIC TREATMENT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although dopamine replacement therapy remains a core component of Parkinson's disease treatment, the onset of motor fluctuations and dyskinetic movements might require a range of medical and surgical approaches from a multidisciplinary team, and important new approaches in the delivery of dopamine replacement are becoming available. The more challenging, wide range of non-motor symptoms can also have a major impact on the quality of life of a patient with Parkinson's disease, and requires careful multidisciplinary management using evidence-based knowledge, as well as appropriately tailored strategies according to the individual patient's needs. Disease-modifying therapies are urgently needed to prevent the development of the most disabling refractory symptoms, including gait and balance difficulties, cognitive impairment and dementia, and speech and swallowing impairments. In the third paper in this Series, we present the latest evidence supporting the optimal treatment of Parkinson's disease, and describe an expert approach to many aspects of treatment choice where an evidence base is insufficient.
引用
收藏
页码:305 / 324
页数:20
相关论文
共 50 条
  • [21] Parkinson's Disease and Motor Fluctuations
    Hinson, Vanessa K.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (03) : 186 - 199
  • [22] Parkinson's disease: surgical options.
    Hammerstad J.
    Hogarth P.
    Current Neurology and Neuroscience Reports, 2001, 1 (4) : 313 - 319
  • [23] Surgical Management of Parkinson's Disease in the Elderly
    Azevedo, Paula
    Aquino, Camila C.
    Fasano, Alfonso
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (04): : 500 - 509
  • [24] Current surgical treatments for Parkinson’s disease and potential therapeutic targets
    Darrin J.Lee
    Robert F.Dallapiazza
    Philippe De Vloo
    Andres M.Lozano
    Neural Regeneration Research, 2018, (08) : 1342 - 1345
  • [25] Current surgical treatments for Parkinson's disease and potential therapeutic targets
    Lee, Darrin J.
    Dallapiazza, Robert F.
    De Vloo, Philippe
    Lozano, Andres M.
    NEURAL REGENERATION RESEARCH, 2018, 13 (08) : 1342 - 1345
  • [26] Drug treatments for the neuropsychiatric complications of Parkinson's disease
    Connolly, Barbara S.
    Fox, Susan H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (12) : 1439 - 1449
  • [27] New treatments for the motor symptoms of Parkinson's disease
    Vijverman, Anne-Catherine
    Fox, Susan H.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 761 - 777
  • [28] Available and emerging treatments for Parkinson's disease: a review
    Hickey, Patrick
    Stacy, Mark
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 241 - 254
  • [29] Surgical Treatment of Parkinson’s Disease
    C. Sidiropoulos
    R. Walsh
    S. Meoni
    Elena Moro
    Current Treatment Options in Neurology, 2012, 14 : 211 - 212
  • [30] The Surgical Management of Parkinson's Disease
    Ponce, Francisco A.
    Lozano, Andres M.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (06) : 685 - 692